ATF3 is involved in rSjP40-mediated inhibition of HSCs activation in Schistosoma japonicum-infected mice.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101083777 Publication Model: Print Cited Medium: Internet ISSN: 1582-4934 (Electronic) Linking ISSN: 15821838 NLM ISO Abbreviation: J Cell Mol Med Subsets: MEDLINE
    • Publication Information:
      Publication: Oxford, England : Wiley-Blackwell
      Original Publication: Bucharest : "Carol Davila" University Press, 2000-
    • Subject Terms:
    • Abstract:
      Schistosomiasis is a parasitic disease characterized by liver fibrosis, a process driven by the activation of hepatic stellate cells (HSCs) and subsequent collagen production. Previous studies from our laboratory have demonstrated the ability of Schistosoma japonicum protein P40 (SjP40) to inhibit HSCs activation and exert an antifibrotic effect. In this study, we aimed to elucidate the molecular mechanism underlying the inhibitory effect of recombinant SjP40 (rSjP40) on HSCs activation. Using a cell model in which rSjP40 inhibited LX-2 cell activation, we performed RNA-seq analyses and identified ATF3 as the most significantly altered gene. Further investigation revealed that rSjP40 inhibited HSCs activation partly by suppressing ATF3 activation. Knockdown of ATF3 in mouse liver significantly alleviated S. japonicum-induced liver fibrosis. Moreover, our results indicate that ATF3 is a direct target of microRNA-494-3p, a microRNA associated with anti-liver fibrosis effects. rSjP40 was found to downregulate ATF3 expression by upregulating microRNA-494-3p in LX-2 cells. This downregulation led to the inhibition of the expression of liver fibrosis proteins α-SMA and COL1A1, ultimately alleviating liver fibrosis caused by S. japonicum.
      (© 2024 The Author(s). Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.)
    • References:
      Cell Death Dis. 2016 Jul 28;7(7):e2315. (PMID: 27468691)
      J Cell Mol Med. 2018 Nov;22(11):5486-5493. (PMID: 30091834)
      Nat Immunol. 2014 Feb;15(2):152-60. (PMID: 24317040)
      Ann Rheum Dis. 2016 Mar;75(3):586-92. (PMID: 25589515)
      Cells. 2020 Jul 23;9(8):. (PMID: 32717951)
      FASEB J. 2018 Sep;32(9):4798-4803. (PMID: 29608331)
      JHEP Rep. 2024 Jan 24;6(3):101014. (PMID: 38379585)
      PLoS Negl Trop Dis. 2021 Jun 23;15(6):e0009472. (PMID: 34161325)
      PLoS One. 2013 Jun 19;8(6):e68479. (PMID: 23840855)
      BioDrugs. 2013 Feb;27(1):25-34. (PMID: 23329398)
      Parasitology. 2011 Jul;138(8):1003-10. (PMID: 21679490)
      Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2021 Jun 22;33(3):225-233. (PMID: 34286522)
      Cell Death Dis. 2020 Dec 14;11(12):1066. (PMID: 33311456)
      Lancet. 2006 Sep 23;368(9541):1106-18. (PMID: 16997665)
      Parasitol Res. 2015 Nov;114(11):4251-7. (PMID: 26268567)
      Parasit Vectors. 2019 May 31;12(1):279. (PMID: 31151477)
      Parasite Immunol. 2017 Feb;39(2):. (PMID: 28160510)
      J Exp Med. 2009 Aug 3;206(8):1681-90. (PMID: 19635859)
      Sci Rep. 2017 Mar 21;7(1):275. (PMID: 28325896)
    • Contributed Indexing:
      Keywords: Schistosoma japonicum; ATF3; Schistosoma japonicum protein P40; hepatic stellate cell; microRNA‐494‐3p
    • Accession Number:
      0 (Activating Transcription Factor 3)
      0 (MicroRNAs)
      0 (Helminth Proteins)
      0 (p40 egg antigen, Schistosoma)
      0 (Atf3 protein, mouse)
      0 (Actins)
      0 (Antigens, Helminth)
    • Publication Date:
      Date Created: 20240720 Date Completed: 20240720 Latest Revision: 20241002
    • Publication Date:
      20241003
    • Accession Number:
      PMC11190947
    • Accession Number:
      10.1111/jcmm.18458
    • Accession Number:
      39031798